article thumbnail

How VMS BioMarketing Accelerated Digital Transformation with Silverline

Silver Line CRM

Reading time: 4 minutes A patient support network isn’t made up of just doctors or nurses. Through contracting with pharmaceutical and biotech companies, VMS BioMarketing provides clinical educator solutions focused on empowering healthcare providers and patients through product support, education, and training.

article thumbnail

Preparing for stricter standards on substances of human origin

European Pharmaceutical Review

Background on BCT legislation in the EU Every year EU patients are treated with 25 million blood transfusions, a million cycles of medically assisted reproduction, over 35,000 transplants of stem cells and hundreds of thousands of replacement tissues.

Safety 65
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A Primer on Telepharmacy

Nixon Gwilt Law

Some of the country’s largest healthcare companies (e.g., CVS, Walgreens, and Optum) are using telepharmacy as part of their long-term strategy to deliver whole-person healthcare. Due to the success of the North Dakota Telepharmacy Project, the Board of Pharmacy in North Dakota permanently implemented telepharmacy regulations in 2003.

Medical 52
article thumbnail

Healthcare Price Transparency is Here. Now What?

Clarify Health

The Future of Healthcare’s Price Transparency is Here. Healthcare providers and insurers are now required to publicly disclose what they pay hospitals, doctors, and other medical providers. We’re in phase 1 of healthcare’s price transparency movement – internet data dump – but what’s next?

article thumbnail

Healthcare Price Transparency is Here. Now What?

Clarify Health

Recorded Session from the 2022 Consumer Experience & Digital Health Forum The Future of Healthcare’s Price Transparency is Here. Healthcare providers and insurers are now required to publicly disclose what they pay hospitals, doctors, and other medical providers.

article thumbnail

Building CO2-neutral, defossilised supply chains for chemicals

European Pharmaceutical Review

Furthermore, entire value chains must be redesigned and the CO 2 emitters (especially point source emitters), chemical industry and power sector, downstream users, eg, healthcare industries and their customers, and healthcare providers need to be coordinated, informed, sensitised and must work out contractual frameworks to de-risk the investments.